Lack of evidence raises questions on long-term PPI use

There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...

A new national approach to pain management

The new National Strategic Action Plan for Pain Management offers plenty of opportunities for pharmacists to work to their full scope of practice. The Action...

6CPA program audits coming

Programs funded under the Sixth Community Pharmacy Agreement (6CPA) will be subject to audits from next week to detect any inaccurate or ineligible claims. The...

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Re-thinking opioids

Pharmacists can minimise opioid harm by helping patients step down. While opioids play an important role in the management of acute pain, their widespread use...

Realising pharmacists’ full potential

We are working to achieve the 11 key actions in Pharmacists in 2023 to unlock opportunities for pharmacists as the custodians of medicine safety. I was...